Stockreport

Theriva™ Biologics Announces Upcoming Presentations at Medical Meetings

Theriva Biologics, Inc.  (TOVX) 
PDF - VCN-01 expanded mPDAC data from VIRAGE Phase 2b trial to be presented at ESMO 2025 - - SYN-004 Interim blinded safety and pharmacokinetic data to be presented at IDWe [Read more]